TY - JOUR AU - Gutierrez, Antonio AU - Bento, Leyre AU - Novelli, Silvana AU - Martin, Alejandro AU - Gutierrez, Gonzalo AU - Queralt Salas, Maria AU - Bastos-Oreiro, Mariana AU - Perez, Ariadna AU - Hernani, Rafael AU - Cruz Viguria, Maria AU - Lopez-Godino, Oriana AU - Montoro, Juan AU - Piñana, Jose Luis AU - Ferra, Christelle AU - Parody, Rocio AU - Martin, Carmen AU - Español, Ignacio AU - Yañez, Lucrecia AU - Rodriguez, Guillermo AU - Zanabili, Joud AU - Herrera, Pilar AU - Varela, Maria Rosario AU - Sampol, Antonia AU - Solano, Carlos AU - Caballero, Dolores PY - 2022 DO - 10.3390/cancers14112673 SN - 2072-6694 UR - http://hdl.handle.net/10668/20899 T2 - Cancers AB - Allo-SCT is a curative option for selected patients with relapsed/refractory (R/R) MCL, but with significant NRM. We present the long-term results of patients receiving allo-SCT in Spain from March 1995 to February 2020. The primary endpoints were... LA - en PB - MDPI KW - CAR-T cell therapy KW - Acute graft-versus-host disease KW - Allogeneic stem-cell transplantation KW - Graft-versus-lymphoma effect KW - Mantle cell lymphoma KW - Non-relapse mortality KW - Target therapy KW - Siblings KW - Chronic Disease KW - Graft vs Host Disease KW - Neoplasm Recurrence, Local KW - Transplantation Conditioning TI - Allogeneic Stem Cell Transplantation in Mantle Cell Lymphoma; Insights into Its Potential Role in the Era of New Immunotherapeutic and Targeted Therapies: The GETH/GELTAMO Experience. TY - research article VL - 14 ER -